Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

DMAG enters phase I

July 26, 2004

Access updates progress of AP-5346

July 26, 2004

FDA to grant additional six months pediatric exclusivity to clofarabine

July 26, 2004

Celera Genomics and Seattle Genetics to develop antibody therapies for cancer

July 26, 2004

TGF-beta inhibitors described in patent literature

July 23, 2004

Kahalalide F enters phase II trials in NSCLC and melanoma

July 23, 2004

Juvaris BioTherapeutics in collaborative research agreement with Cell Genesys

July 23, 2004

Plan established with FDA for sBLA filing for Erbitux

July 23, 2004

Novel antiinflammatory agents trigger apoptosis in cancer cell lines

July 22, 2004

Eligard six-month product submitted for approval in Canada

July 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...